David Taber to Cyclosporine
This is a "connection" page, showing publications David Taber has written about Cyclosporine.
Connection Strength
0.298
-
Does bioequivalence between modified cyclosporine formulations translate into equal outcomes? Transplantation. 2005 Dec 15; 80(11):1633-5.
Score: 0.240
-
Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer. Cancer Chemother Pharmacol. 2005 Oct; 56(4):421-6.
Score: 0.058